{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(1)"],"submitter":["Weissler EH"],"pubmed_abstract":["<h4>Importance</h4>Thoracic endovascular aortic repair (TEVAR) has increasingly been used for uncomplicated type B aortic dissection (uTBAD) despite limited supporting data.<h4>Objective</h4>To assess whether initial TEVAR following uTBAD is associated with reduced mortality or morbidity compared with medical therapy alone.<h4>Design, setting, and participants</h4>This cohort study included Centers for Medicare & Medicaid Services inpatient claims data for adults aged 65 years or older with index admissions for acute uTBAD from January 1, 2011, to December 31, 2018, with follow-up available through December 31, 2019.<h4>Exposures</h4>Initial TEVAR was defined as TEVAR within 30 days of admission for acute uTBAD.<h4>Main outcomes and measures</h4>Outcomes included all-cause mortality, cardi"],"journal":["JAMA cardiology"],"pagination":["44-53"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9637274"],"repository":["biostudies-literature"],"pubmed_title":["Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection."],"pmcid":["PMC9637274"],"pubmed_authors":["Weissler EH","Osazuwa-Peters OL","Jones WS","O'Brien SM","Vekstein AM","Shalhub S","Mark DB","Hardy NC","Kougias P","Mussa FF","Patel MR","Secemsky EA","Greiner MA","Vemulapalli S"],"additional_accession":[]},"is_claimable":false,"name":"Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection.","description":"<h4>Importance</h4>Thoracic endovascular aortic repair (TEVAR) has increasingly been used for uncomplicated type B aortic dissection (uTBAD) despite limited supporting data.<h4>Objective</h4>To assess whether initial TEVAR following uTBAD is associated with reduced mortality or morbidity compared with medical therapy alone.<h4>Design, setting, and participants</h4>This cohort study included Centers for Medicare & Medicaid Services inpatient claims data for adults aged 65 years or older with index admissions for acute uTBAD from January 1, 2011, to December 31, 2018, with follow-up available through December 31, 2019.<h4>Exposures</h4>Initial TEVAR was defined as TEVAR within 30 days of admission for acute uTBAD.<h4>Main outcomes and measures</h4>Outcomes included all-cause mortality, cardi","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Jan","modification":"2025-04-05T12:28:52.094Z","creation":"2025-04-05T12:28:52.094Z"},"accession":"S-EPMC9637274","cross_references":{"pubmed":["36334259"],"doi":["10.1001/jamacardio.2022.4187"]}}